Myelinated axons segregate the axonal membrane into four defined regions: the node of Ranvier, paranode, juxtaparanode, and internode. The paranodal junction consists of specific component proteins, such as neurofascin155 (NF155) on the glial side, and Caspr and Contactin on the axonal side. Although paranodal junctions are thought to play crucial roles in rapid saltatory conduction and nodal assembly, the role of their interaction with neurons is not fully understood. In a previous study, conditional NF155 knockout in oligodendrocytes led to disorganization of the paranodal junctions. To examine if disruption of paranodal junctions affects neuronal gene expression, we prepared total RNA from the retina of NF155 conditional knockout, and performed expression analysis. We found that the expression level of 433 genes changed in response to paranodal junction ablation. Interestingly, expression of aquaporin 3 (AQP3) was significantly reduced in NF155 conditional knockout mice, but not in cerebroside sulfotransferase knockout (CST-KO) mice, whose paranodes are not originally formed during development. Copy number variations have an important role in the etiology of schizophrenia (SCZ). We observed rare duplications of AQP3 in SCZ patients, suggesting a correlation between abnormal AQP3 expression and SCZ. To determine if AQP3 over-expression in NF155 conditional knockout mice influences neuronal function, we performed adeno-associated virus (AAV)-mediated over-expression of AQP3 in the motor cortex of mice and found a significant increase in caspase 3-dependent neuronal apoptosis in AQP3-transduced cells. This study may provide new insights into therapeutic approaches for SCZ by regulating AQP3 expression, which is associated with paranodal disruption.
Oligodendrocytes are glial cells that myelinate neuronal axons in the central nervous system (CNS). Myelin insulates axons to increase conduction velocity of neuronal action potentials (Nave 2010) . Myelin is also important for neuronal maintenance by metabolically supporting axons through transport of lactate or pyruvate (Lee et al. 2012 ).
An imbalance of the inhibitory-excitatory activities within the neural network in the CNS can cause psychiatric diseases (Cui et al. 2016) . White matter abnormalities can also play roles in psychiatric diseases, especially during the juvenile and adolescent periods (White et al. 2015) . Several studies have demonstrated that a decrease in oligodendrocyte number and altered expression of myelin/oligodendrocyte-related genes in schizophrenia (SCZ) patients could affect white matter morphology and neuronal connectivity, which are characteristic features of SCZ (Martins-de-Souza et al. 2009) . Recent studies have shown that several proteins localized to the nodes of Ranvier, such as neurofascin, contactins, and ankyrin G, are also affected in SCZ (Roussos et al. 2012 ). In addition, some studies have shown that reduced expression of these junctional proteins leads to axonal degeneration even in the absence of gross demyelination Taylor et al. 2017) . Paranodal junctions are also known to execute several functions including the maintenance of action potential propagation (Rasband et al. 1999) , segregation of axonal surface proteins (Rios et al. 2003) , and signal transduction between axon and glia (Michailov et al. 2004) . Combined, these data suggest that pathological changes in the white matter are causative factors of SCZ.
Over-expression of proteolipid protein 1 (PLP), a major component of the myelin sheath, causes oligodendrocyte dysfunction in PLP 4e/À mice (Kagawa et al. 1994) , including abnormal paranodal junctions during the early phase (Tanaka et al. 2009 ) and later demyelination. Our previous studies have reported that early-phase PLP 4e/À mice display behavioral abnormalities related to cognitive dysfunction, which is one of the characteristic features of SCZ-like behaviors (Tanaka et al. 2009 ). It has also been reported that social isolation of both young and adult mice leads to behavioral and cognitive dysfunction, partially caused by myelination defects in the prefrontal cortex (Liu et al. 2012; Makinodan et al. 2012) . Conversely, administration of a drug that enhances myelination to socially isolated mice rescues the behavioral changes and improves myelination in the prefrontal cortex . These findings suggest that myelination plays essential roles in cognitive function in these mouse models.
Recently, Yamazaki et al. (2010) showed that depolarization of an oligodendrocyte modulates the conduction velocity of the axons myelinated by the oligodendrocyte. Therefore, oligodendrocytes/myelin actively communicate with axons to modulate various properties of the neurons. Given that individual oligodendrocytes can myelinate multiple axons from the motor cortex and sensory cortex in the corpus callosum (Osanai et al. 2017) , it is possible that oligodendrocytes mediate information processing between these cortical regions. This could explain the poor cognitive function caused by white matter abnormalities. Furthermore, conduction velocity deficits can influence the expression of oligodendroglial and neuronal genes (Roussos et al. 2012) . Combined, these reports suggest that the disruption of oligodendroglial paranodal junctions influences their counterpart axons, eventually affecting neuronal gene expression and function. However, this hypothesis remains to be tested.
In this study, we investigated how neurons are affected by the disruption of paranodal junctions on their axons. We took advantage of conditional ablation of NF155 in myelinating oligodendrocytes (Plp-CreERT;NF155
Flox/Flox mice; Doerflinger et al. 2003; Pillai et al. 2009 ). The mice display a gradual loss of paranodal junctions and a concomitant disorganization of axonal domains (Pillai et al. 2009 ). We found that the expression level of various neuronal genes changed in response to the ablation of paranodal junctions. Interestingly, we found that the expression of some genes in Plp-CreERT;NF155
Flox/Flox mice significantly differed from controls, but were unaffected in cerebroside sulfotransferase knockout (CST-KO) mice, whose paranodes fail to form during development. Copy number variations (CNVs), a major source of genetic variation in the human genome, are an important factor in the risk for SCZ (Stewart et al. 2011) . Here, we identified that duplications of aquaporin3 (AQP3), whose expression was decreased in Plp-CreERT;NF155 Flox/ Flox mice, were significantly associated with risk of SCZ. We further demonstrated that AQP3 over-expression in PlpCreERT;NF155 Flox/Flox mice led to an increase in both neuronal swelling and caspase 3-dependent apoptosis. These findings suggest that the abnormal AQP3 expression affects neuronal viability and may be involved in the pathogenesis of SCZ caused by oligodendrocyte abnormalities.
Material and methods

Animals
No blinding, no randomization, and no sample calculation were performed. This study was not pre-registered. The transgenic mice of both sexes (body weight; 25-35 g) used in this study were generated and genotyped as described previously: Plp-CreERT; NF155 Flox/Flox mice (Doerflinger et al. 2003; Pillai et al. 2009);  cerebroside sulfotransferase knockout mice (CST-KO mice; RRID: IMSR_RBRC00962; Ishibashi et al. 2002; Honke et al. 2002) ; proteolipid protein 1 transgenic mice (PLP 4e/À mice; Kagawa et al. 1994 
Tamoxifen treatment
Tamoxifen administration experiments were carried out according to a previous report (Pillai et al. 2009 ). In brief, Tamoxifen (Cat# 205-14363, Wako, Osaka, Japan) was dissolved at 10 mg/mL in sunflower oil by sonicating at 36°C for 30 minutes. Plp-CreERT; NF155 +/Flox or Plp-CreERT;NF155 Flox/Flox mice were intraperitoneally injected with 10 mg/mL tamoxifen for 10 consecutive days beginning at P23. We refer to them hereafter as Plp-NF155 +/Flox and the Plp-NF155 Flox/Flox mice, respectively. The animals were then killed at various time points as described in the Results section.
Mouse tissue preparation
For histological analysis, mice were deeply anesthetized with an intraperitoneal injection of sodium pentobarbital (70 mg/kg) and perfused transcardially with 4% paraformaldehyde in 0.1 M sodium phosphate buffer. Brains were post-fixed in 4% paraformaldehyde overnight at 4°C. The optic nerves were post-fixed in 4% paraformaldehyde for 1 min at 24°C. The post-fixed tissues were cryoprotected in phosphate-buffered saline (PBS) containing 20% sucrose overnight, embedded in optimal cutting temperature (OCT) compound (Cat# 4583, Sakura Finetechnical Co., Tokyo, Japan), and cut into 20 lm (brain) or 10 lm (optic nerve) sections using a cryostat (CM3050S, Leica CM3050, Wetzlar, Germany) for in situ hybridization and immunohistochemistry.
In situ hybridization Digoxigenin (DIG)-labeled single stranded riboprobes for AQP3 (GenBank Accession Number, NM_016689) were synthesized using T7 RNA polymerase and DIG RNA labeling mix (Cat# 11277073910, Roche, Mannheim, Germany). The protocol for in situ hybridization has been previously described (Ma et al. 2006 RT-PCR and qRT-PCR Total RNA was isolated using a Sepasol G kit (Cat# 09379, Nacalai Tesque, Kyoto, Japan) according to the manufacturer's instructions. The first-strand cDNA was synthesized using ReverTra Ace (Cat# TRT-101, Toyobo, Osaka, Japan). PCR was performed using KAPA Taq Extra PCR kit (Cat# KK3606, Kapa Biosystems, Wilmington, USA). For the quantitative PCR, SYBR Master Mix Reagent (Cat# 04707516001, Takara, Otsu, Japan) was used and then subjected to real-time PCR quantification using an ABI7300 (Applied Biosystems, Waltham, MA, USA). Quantitative PCR analysis was performed using a StepOne analyzer (Life Technologies). The PCR reaction program consisted of 40 cycles of denaturation at 95°C for 15 s and annealing and elongation at 60°C for 1 min. To discriminate specific amplification from non-specific amplification, melting curve analysis was performed after each PCR reaction. To determine the starting amount of cDNA, each purified PCR product of known concentration was serially diluted and used as a standard. b-actin was used as a housekeeping gene to normalize all PCR data; GAPDH was also used as an additional internal control for further confirmation in Plp-NF155 Flox/Flox mice and CST-KO mice (Figure S1 ). All PCR primer sequences are described in Table 1 .
Expression analysis in response to the disruption of paranodal junctions Total RNA prepared from mouse retina was isolated using NucleoSpin RNA kit (Cat# 740955, Takara) according to the manufacturer's instructions. Total RNA concentration was measured spectrophotometrically with a NanoDrop. The quality of purified total RNA was verified by an Agilent 2100 bioanalyzer (Agilent technologies, Santa Clara, CA, USA). Isolated total RNA was amplified and labeled according to a previously described method in the One-Color Microarray-Based Gene Expression Microarrays Analysis Protocol (Agilent Technologies). Briefly, total RNA (100 ng) was converted into cDNA using the Low Input Quick Amp Labeling Kit (Cat# 5190, Agilent Technologies), followed by in vitro transcription and incorporation of Cyanine 3-CTP into cRNA. Cyanine 3-labeled cRNA was purified using RNeasy Mini kit (Cat# 74104, Qiagen, Hilden, Germany). After fragmentation, labeled cRNA was hybridized to SurePrint G3 Mouse Gene Expression 8 9 60K Microarray (Cat# G4858A, Agilent Technologies) for 17 h at 65°C. The microarray was scanned by an Agilent Scanner, and the scan image data was analyzed with Feature Extraction software (Agilent Technologies). After background signal subtraction, the data for two microarray samples were managed and analyzed using the GeneSpring GX software (Agilent Technologies). A total of 55 821 probes were used for this analysis.
Raw intensity values were normalized to the 50-percentile shift and then subjected to a Bayesian correction based on the median of the control samples. Altered transcripts were identified using the comparative method with the log 2 normalized intensity values between Plp-NF155 Flox/Flox mouse and control samples.
Genetic analysis of candidate genes in schizophrenia patients
Expression analysis revealed that over 400 genes were differentially up-regulated or down-regulated between Plp-NF155 Flox/Flox and Plp-NF155 +/Flox mice. For genetic analysis in SCZ patients, we manually extracted genes which exert an effect on neuronal function. Furthermore, we focused on two gene candidates whose expression was altered only in Plp-NF155 Flox/Flox mice, but not in CST-KO mice, and explored whether the candidate genes were associated with a risk for SCZ. We examined the published CNV datasets of SCZ cases and psychiatrically normal controls (Kushima et al. 2017) . In brief, we analyzed 1699 cases with SCZ and 824 psychiatrically normal controls using high-resolution (> 10 kb) array comparative genomic hybridization (aCGH). Genomic DNA extracted from blood or saliva samples was used in CNV analysis. NimbleGen 720k Whole-Genome Tiling arrays were used for genome-wide CNV screening. CNV calls were made with Nexus Copy Number software v.7.5 (BioDiscovery, El Segundo, CA, USA) using the Fast Adaptive States Segmentation Technique 2 algorithm, which is a hidden Markov model-based approach. Differences in frequency of CNVs between cases and controls were evaluated using the one-sided Fisher's exact test, with significance set at p < 0.05.
Transfection of expression vectors into Neuro2A
Mouse AQP3 (NM_016689) cDNA was cloned from female mouse brain total RNA by RT-PCR. pCX-EGFP vector was purchased from Clontech Laboratories (Cat# 15007, CA, USA). AQP3-2A-peptide-EGFP and EGFP cDNAs were constructed using the AQP3 and/or pCX-EGFP constructs as backbone. To construct pAAV-AQP3-2A-EGFP and pAAV-EGFP, the AQP3-2A-peptide-EGFP or EGFP cDNAs were subcloned into the pAAV vector. Neuro2A cells were grown in Dulbecco's modified Eagle's medium (Cat# 08456, Nacalai Tesque, Kyoto, Japan) supplemented with 10% fetal bovine serum (Cat# 2917254, MP Biomedicals, Santa Ana, VA, USA), and 1% penicillin/streptomycin (PS; Cat# 15140122, Gibco, Grand Island, USA), and maintained at 37°C in a humidified atmosphere with 5% CO 2 . One day before transfection, Neuro2A (2. without serum, and combined the diluted DNA and diluted Lipofectamine 2000 (total volume was 500 lL). The transfection complex (500 lL) was applied to each well containing Neuro2A cells in 2 mL of growth medium without antibiotics. After 4 h of incubation, the medium was changed to growth medium and the cells were maintained for an additional 48 h.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde in 0.1 M PBS for 10 min and then permeabilized with 0.1% Triton X-100 for an additional 10 min. After incubation in blocking solution (1% goat serum/PBS) for 1 h, mouse rabbit anti-AQP3 (1 : 200; Cat# sc-20811, Santa Cruz Biotechnology) and rat anti-GFP (1 : 1000; Cat# 04404-84, Nacalai Tesque, Kyoto, Japan) antibodies diluted in blocking solution were applied and incubated overnight at 4°C. After washing in PBS, cells were incubated with secondary antibodies (1 : 2000; Alexa 568-conjugated goat anti-rabbit IgG (Cat# A-11011) and Alexa 488-conjugated goat anti-rat IgG (Cat# A-11006); Molecular Probes) and Hoechst 33342 (0.1 lg/mL; Sigma) for 3 h at 24°C. Immunofluorescent signals were observed under a Nikon A1R Confocal Microscope (Tokyo, Japan).
Adeno-associated virus (AAV) production and purification All adeno-associated virus (AAV) vectors were produced and purified as described previously (Matsushita et al. 1998; Okada et al. 2005; Kobayashi et al. 2016) . In brief, HEK293 cells anesthetized with an intraperitoneal injection of ketamine/xylazine solution (100 and 5 mg/kg, respectively) and placed in a stereotaxic frame (Cat# SR-5M-HT, Narishige, Tokyo, Japan) with a mouse adapter. After opening the skull at the injection site, 0.2-0.25 lL of viral solution (0.5 9 10 9 viral genome [vg] ) was injected into the motor cortex (0.5 mm anterior and 1.2 mm lateral to the bregma, at a depth of 0.4 mm) through pulled glass pipettes (outer diameter 40-60 lm) using an air pressure system, which took about 3 min. The pipette was withdrawn 3 min after the viral administration. Incisions were closed using wound clips. The mice were killed 30 days after AAV injection.
Data analyses
All statistics were analyzed with GraphPad Prism 6 Software (GraphPad Software, Inc., San Diego, CA, USA). Significant differences in comparisons of the two groups were evaluated using Student's t-test. Multiple group comparisons were performed by one-way ANOVA followed by Tukey's post hoc tests. The criterion for a significant difference was p < 0.05 for all statistical evaluation. Data presented showed all the replicates and as the mean AE SEM. To evaluate the difference in frequencies of clinically significant CNVs between SCZ cases and controls, p-values were calculated with a one-sided Fisher's exact test.
Results
Expression profiles of neuronal genes in response to disruption of paranodal junctions Disruption of paranodal junctions occurs during the early phase of demyelinating diseases (C ß olako glu et al. (Fig. 1b) . In Plp-NF155
Flox/Flox mice 60 days after tamoxifen administration, both the number and length of NF155 + clusters were significantly reduced compared to Plp-NF155 +/Flox mice (number, p < 0.001; length, p < 0.05; Fig. 1c and d) . We also observed an apparent decrease in Caspr-positive signals in the optic nerves of Plp-NF155
Flox/Flox mice (number and length, p < 0.01; Fig. 1e and f) . These results are consistent with previous studies showing that NF155 mutations induce disruption of the paranodal junctions in the peripheral nervous system (Pillai et al. 2009 ).
To examine gene expression profiles in the retina of Plp-NF155 Flox/Flox mice, expression analysis was performed with total retinal RNA isolated from Plp-NF155 +/ Flox or Plp-NF155 Flox/Flox mice 60 days after tamoxifen administration. The expression level of various neuronal genes was significantly changed in response to the ablation of the paranodal junctions (Fig. 1g) Fig. 1g: decorin (DCN) , myosin heavy polypeptide 11 (MYH11), pituitary tumortransforming gene 1 (PTTG1), dopachrome tautomerase (DCT), TELO2 interacting protein 2 (TTI2), and aquaporin 3 (AQP3). DCN and MYH11 are neuronal survival factors signaling through TGF-b and IGF-1 (Iozzo et al. 2011; Renard et al. 2013) , respectively. PTTG1 and DCT are involved in tumor development (Lee et al. 1999; Pak et al. 2004) , whereas TTI2 is a regulator of the DNA damage response (Hurov et al. 2010) , and AQP3 functions in the transport of water molecules within a cell (Preston et al. 1992) . The primers used for PCR amplification are listed in Table 1 . The up-or down-regulation of gene expression detected by qRT-PCR was identical to that obtained in the expression analysis, supporting our expression profiles (DCN, MYH11, DCT, TTI2, and AQP3, p < 0.05; PTTG1, p < 0.01; Fig. 1h and i) . These findings suggest that neuronal function is affected by the altered gene expression caused by paranodal abnormalities.
Comparison of retinal gene expression between Plp-NF155
Flox/Flox and CST-KO mice in response to paranodal disruption The expression analysis indicated that the gradual loss of paranodal junctions after their initial formation alters neuronal gene expression. We next examined whether expression levels of our focal genes were also affected in another mutant mouse line whose paranodes never form during development. This mutant mouse line lacks the cerebroside sulfotransferase (CST) enzyme, which synthesizes sulfatide, one of the major lipid components of the myelin sheath (Eckhardt et al. 2007 ). Ishibashi et al. (2002) reported that CST mutant mice do not form paranodal junctions during development but show normal ion channel localizations on axons until 6 weeks of age. Previous studies have shown that CST-KO mice undergo a switch from axonal voltage-dependent sodium channel (Nav) 1.2 to Nav1.6 during development (Suzuki et al. 2004) , while increased amounts of Nav1.2 and its aberrant localization are observed in PLP 4e/À mice, whose paranodes are disrupted after initial formation (Rasband et al. 2003) . Since dysregulation of axonal Nav isoforms can influence neuronal function, we compared the expression levels of our focal genes in the retina of 4-or 6-week-old CST-KO mice to those of Plp-NF155 Flox/Flox mice 40 or 60 days after tamoxifen administration. While DCN and MYH11 expression were also induced in CST-KO mice (compared to Plp-NF155 Flox/Flox mice: DCN and MYH11, p < 0.05; CST-KO mice: DCN (6w) and MYH11 (6w), p < 0.05, DCN (4w), p < 0.01; Fig. 2a-d) , the response of the other focal genes differed between Plp-NF155 Flox/Flox and CST-KO mice. The expression of PTTG1 and AQP3 was significantly altered in Plp-NF155 Flox/Flox mice (PTTG1, p < 0.01; AQP3, p < 0.05; Fig. 2e and g ) but not in CST-KO mice (PTTG1 and AQP3, p > 0.05; Fig. 2f and h ). These data indicate that some genes are only affected by disruption of paranodes after their initial formation, but not by an initial lack of paranodal development.
AQP3, whose expression is decreased by paranodal disruption, is linked to schizophrenia by CNV analysis
We previously reported that SCZ-related behaviors in mice are associated with abnormal paranodal structures (Tanaka et al. 2009 ). In SCZ patients, the disruption of myelin, including the paranodal junction, occurs after its initial formation (Roussos et al. 2012) . Therefore, we investigated whether PTTG1 and AQP3 genes identified in our expression analysis were linked to CNV of SCZ. Intriguingly, the locus encoding AQP3 displayed a characteristic CNV pattern. We found that duplications of the AQP3 locus were detected in eight SCZ patients (n = 1699), but not in controls (n = 824; Fig. 3a) . The excess of the duplications in SCZ cases was statistically significant (one-sided Fisher's exact test p = 0.042). We identified no CNVs at the PTTG1 locus. Together SCZ-related behaviors in mice are associated with abnormal paranodal structures (Tanaka et al. 2009 ), our CNV analyses suggest that the reduction in AQP3 expression caused by paranodal disruption may function in the pathogenesis of SCZ.
AQP3 over-expression in the motor cortex of Plp-NF155
Flox/Flox mice decreases cell volume and induces caspase 3 activation AQP3 was one of the genes highly down-regulated in the retina of Plp-NF155 Flox/Flox mice, but not in CST-KO mice. AQP3 has been reported to control the cellular uptake of H 2 O and influence intracellular signaling in mammalian cells (Gal an-Cobo et al. 2015) . Moreover, AQP-mediated water transport is involved in brain volume regulation, cerebrospinal fluid movement, and metabolism (Verkman 2005) . We therefore examined whether AQP3 expression is also affected in the cerebral cortex of Plp-NF155 Flox/Flox mice in addition to the retina. qRT-PCR analysis revealed a significant decrease in AQP3 expression in the cortex of Plp-NF155 Flox/Flox mice (p < 0.05; Fig. 3b ). In our previous study using demyelinating PLP 4e/À mice, slightly abnormal paranodal structures were observed at 2 months of age (Tanaka et al. 2009 ). We found that AQP3, whose expression was altered in Plp-NF155 Flox/Flox mice but not in CST-KO mice, was also down-regulated in the cortex of 2-monthold PLP 4e/À mice (p < 0.05; Figure S2 ). In contrast, AQP3 mRNA levels were unchanged in the cerebral cortex of CST-KO mice compared to controls (p > 0.05; Fig. 3c ). The reduced expression of AQP3 in Plp-NF155 Flox/Flox mice was further confirmed by in situ hybridization (Fig. 3d ). These results demonstrate that AQP3 expression is also affected by disruption of paranodal junctions in the cerebral cortex. Next, to examine if AQP3 is expressed in neurons, we performed double immunostaining with anti-AQP3 and anti-NeuN (neuron marker) antibodies (Fig. 3e) . In the Plp-NF155 +/Flox mice, the majority of NeuN-positive neurons had detectable AQP3 immunoreactivity (Fig. 3e and f) , while Plp-NF155 Flox/Flox mice displayed reduced AQP3 expression in NeuN-positive neurons (p < 0.001; Fig. 3e and f) . We found that about 90% of NeuN-positive cells in the cerebral cortex of Plp-NF155 +/Flox mice were positive for AQP3, indicating that AQP3 is primarily expressed in neurons (Fig. 3f) . Furthermore, we found that the ratio of AQP3 mice; Student's t-test; n = 3 each). Abbreviations: SZ, schizophrenia; CONT, control. NFX1, Nuclear transcription factor X-Box binding 1; AQP7, Aquaporin 7; AQP3, Aquaporin 3; NOL6, Nucleolar protein 6; SUGT1P1, SGT1 homolog MIS12 kinetochore complex assembly cochaperone pseudogene 1; ANKRD18B, Ankyrin repeat domain 18B. A one-sided Fisher's exact test was performed; p = 0.042.
volume (Holm et al. 2016) . The combination of these reports and the CNV data from this study suggests a link between alterations in AQP3 expression and neuronal dysfunction. To further address this possibility, we utilized adeno-associated virus (AAV) injection in vivo to determine if over-expression of AQP3 in Plp-NF155 Flox/Flox mice, in which AQP3 expression is reduced, can be implicated in cellular viability. First, to confirm the expression of AQP3 by AAV, Neuro2A cells were transfected with a plasmid encoding the AQP3 gene (pAAV-AQP3-2A-EGFP), and the expression level of AQP3 was compared with control plasmid-transduced cells (pAAV-EGFP). qRT-PCR analysis showed that AQP3 mRNA significantly increased following transfection with pAAV-AQP3-2A-EGFP (p < 0.05; Figure S3a ). Representative immunofluorescent images of AQP3 in AQP3 AAV vector-transduced or control Neuro2A cells indicated that AQP3 protein levels were also increased ( Figure S3b ). Therefore, we injected AAV2-AQP3-2A-EGFP or its control AAV2-EGFP bilaterally into the motor cortex of Plp-NF155 +/Flox and Plp-NF155 Flox/Flox mice 50 days after tamoxifen treatment and visualized AQP3-transduced neurons by GFP expression (Fig. 4a) . Thirty days after AAV2-AQP3-2A-EGFP injection, we observed over-expression of AQP3 in the motor cortex by in situ hybridization (Fig. 4b) . Furthermore, EGFP-positive signals were abundant in the cortical neurons of the motor cortex (Fig. 4c) . To address the effect of AQP3 over-expression on cell volume in Plp-NF155 Flox/Flox mice, cell area was defined based on EGFP fluorescence intensity (Fig. 4d) . In Plp-NF155 +/Flox mice, AQP3 over-expression did not alter cell area (p > 0.05; Fig. 4e ), in contrast to Plp-NF155 Flox/Flox mice in which over-expression of AQP3 significantly decreased cell area (p < 0.001; Fig. 4e ). This suggests that AQP3 over-expression under conditions of paranodal disruption may influence neuronal viability via cellular swelling or water homeostasis. We thus examined whether AQP3 over-expression in Plp-NF155 Flox/Flox mice impacts caspase 3-dependent apoptosis. AQP3 over-expression in Plp-NF155 +/Flox mice had only a slight effect on cleaved caspase 3-positive cells (p > 0.05; Fig. 4f and g ), but induced a marked increase in the number of cleaved caspase 3-positive cells in Plp-NF155 Flox/Flox mice compared to controls (p < 0.001; Fig. 4f and g ). These results indicate that AQP3 over-expression under conditions of paranodal disruption increases neuronal swelling and caspase 3-dependent apoptosis. Together with the CNV data in this study, these results suggest that abnormal AQP3 expression influences neuronal viability and contributes to SCZ.
Discussion
Demyelinating diseases are typical examples of diseases associated with white matter abnormalities. In general, demyelinating diseases are classified as neurological diseases but not psychiatric diseases. However, cognitive dysfunction is observed in patients experiencing demyelination (Malkki 2015) , and white matter abnormalities are found in many SCZ patients (White et al. 2015) . In our previous study using demyelinating PLP 4e/À mice, we observed cognitive dysfunction prior to the onset of demyelination (Tanaka et al. 2009) . In this early stage of the disease, paranodal disruption was observed; thus, we speculated that mild white matter abnormalities, such as paranodal disruption, could result in symptoms observed in SCZ patients.
In this study, we performed expression analysis and qRT-PCR on mouse retinal tissue to explore how the neuronal cell body responds to paranodal disruption. The results revealed that over 400 genes were differentially up-or down-regulated more than twofold from the control level (Fig. 1g) . Interestingly, we observed differences in the expression profiles of several genes between Plp-NF155 Flox/Flox and CST-KO mice (Fig. 2) . For example, the expression levels of AQP3 and PTTG1 were altered in Plp-NF155 Flox/Flox ( Fig. 2e and g ), but remained unchanged in CST-KO mice ( Fig. 2f and h ). These results suggest that some genes are sensitive to paranodal disruption after they are formed, but are not affected by the lack of initial paranodal development. Paranodal junctions act as a seal between the myelin sheath and the axon to isolate them from the extracellular environment (Bhat et al. 2001) . Previous studies have suggested that structural paranodal abnormalities might allow reactive oxygen species and proteases to invade the internodal space (Gonsette 2008; Rosenbluth et al. 2013) ; and the disruption of paranodal junctions in mice results in axonal swelling (Pillai et al. 2009 ). In addition, organelle accumulation was found in the paranodal region flanked by the swollen lesions, a sign of disrupted axonal transport, which eventually leads to axonal degeneration (Garcia-Fresco et al. 2006) . Although the precise molecular mechanisms underlying these events remain to be elucidated, these reports suggest that the disruption of paranodal junctions causes axonal transport deficits and induces cytotoxic stress. Some studies have suggested that sequential phase shifts in sodium channel clustering may affect neuronal properties (Girault and Peles 2002) . Nav1.2 first appears on the axons during development, and is replaced by Nav1.6 in mature neurons (Boiko et al. 2001 ). This transition from Nav1.2 to Nav1.6 occurs in CST-KO mice (Suzuki et al. 2004) . Previous paper reports that the transition from Nav1.2 to Nav1.6 appears to be disturbed as early as 2 months of age in PLP 4e/À mice (Rasband et al. 2003) . In addition, our previous study reported that demyelinating PLP 4e/À mice showed slightly abnormal paranodal structures at 2 months of age (Tanaka et al. 2009) , and the density of Na + channel clusters was significantly affected in PLP 4e/À mice than wild-type mice at the same age . So, we analyzed AQP3 expression at 2 months of age in PLP 4e/À mice. We found that AQP3, whose expression was altered in Plp-NF155 Flox/ Flox mice but not in CST-KO mice, was also down-regulated in the cortex of 2-month-old PLP 4e/À mice (p < 0.05; Figure S2 ). Although it is unclear why the gene expression responses are different between Plp-NF155 Flox/Flox and CST-KO mice, it is possible that the gradual loss of paranodal junctions after its formation might cause neuronal stress and change neuronal characters or functions. Further studies will be required to reveal the gene regulation in response to either early or late disruption of paranode. Microarray analysis comparing Plp-NF155
Flox/Flox and CST-KO mouse data might be helpful to identify molecular mechanisms underlying these different gene expressions.
Immunostaining showed that AQP3 was primarily expressed in neurons ( Fig. 3e and f) . Moreover, expression of AQP3 in the cerebral cortex was significantly decreased in Plp-NF155 Flox/Flox mice compared to Plp-NF155 +/Flox mice group, one-way ANOVA followed by Tukey's post hoc tests; n.s., no significant difference compared to Plp-NF155 +/Flox + AAV2-AQP3-2A-EGFP group, one-way ANOVA followed by Tukey's post hoc tests; n = 6 mice each).
( Fig. 3b and c) , and the decrease was more pronounced in the deeper layers of the cerebral cortex (Fig. 3f) . Cortical neurons in different layers show different profiles of myelination (Tomassy et al. 2014) . The lowest levels of myelin correspond to upper layers, whereas deeper layer neurons are the most densely myelinated (Tomassy et al. 2014) . These findings suggest that the cortical neurons in the deeper layers are more markedly influenced by paranodal abnormalities. However, the functional role of AQP3 after the disruption of paranodal junctions has yet to be fully clarified. The up-regulation of AQP3 was observed in rat brains after focal cerebral ischemia and could contribute to the development of cerebral edema (Yang et al. 2009 ). Conversely, the down-regulation of AQP is essential for defending against severe oxidative stress, indicating potential clinical applications for AQP expression regulation (Te Velde et al. 2008) . Here, we suggest that the disruption of paranodal junctions influences neuronal function through a decrease in AQP3 expression. The reduction in AQP3 expression may be implicated in neuroprotection from cytotoxic stress caused by the disruption of paranodal junctions. Further studies on the function of AQP3 in Plp-NF155 Flox/Flox mice will provide important insights into the roles of gene regulation during the disruption of paranodal junctions.
A growing number of recent reports have demonstrated the involvement of CNV in SCZ (Crespi and Crofts 2012) . As one of the major sources of genetic variation, CNV provides a versatile tool for identifying candidate genes that may contribute to SCZ (Luo et al. 2014) . In this study, by comparing the focal genes in our expression analysis to the list of genes identified with CNVs, we found changes in the expression of susceptibility genes associated with SCZ in response to paranodal disruption. Interestingly, these patients displayed rare duplications of the AQP3 gene (Fig. 3a) . We surmise that the duplication leads to increased gene expression. However, as we could not analyze gene expression levels in our CNV carriers, we are unable to examine whether the duplications actually affect AQP3 gene expression. However, we demonstrated that AQP3 over-expression after paranodal disruption induced the swelling of neurons and caspase 3-dependent apoptosis in motor cortex (Fig. 4d-g ). Subsequent neuronal, dendritic, and synaptic losses associated with increased caspase 3 levels were also found in patients with SCZ (Chen et al. 2009; Gass o et al. 2014) . Structural and functional brain alterations are thought to underlie SCZ, and some of these alterations are observed in motor system (Walther 2015) . Previous studies have identified reduced volumes of the primary and secondary motor cortex in SCZ patients (Douaud et al. 2007; Wang et al. 2018) . Furthermore, altered neuronal activity in the area was related to negative symptom of SCZ (Walther et al. 2017) , suggesting that motor cortex may play a role in SCZ pathogenesis. Although it is difficult to examine whether or how the AQP3 gene confers a risk for SCZ, abnormal AQP3 expression may contribute to dysregulated motor network in SCZ.
In conclusion, our present study revealed that the gradual loss of paranodal junctions in Plp-NF155 Flox/Flox mice altered neuronal gene expression (Fig. 1g) . Based on the correlation between the focal genes identified in our expression analysis and CNV data for SCZ, AQP3 is a candidate for a causative gene that shows rare duplications in SCZ patients (Fig. 3a) . Given that abnormal AQP3 expression in Plp-NF155 Flox/Flox mice was implicated in neuronal viability (Fig. 4d-g ), further understanding of AQP3 function may provide new insights into the etiology of SCZ and potential therapeutic approaches.
Supporting information
Additional supporting information may be found online in the Supporting Information section at the end of the article. Figure S1 . qRT-PCR analysis of the focused gene expression normalized by GAPDH in the retina or cerebral cortex of Plp-NF155
Flox/Flox and CST-KO mice. Figure S2 . AQP3 expression was also reduced in PLP 4e/À mice, similar to that in Plp-NF155 Flox/Flox mice. Figure S3 . Confirmation of AQP3 over-expression in Neuro2A cells transfected with a plasmid-encoding AQP3 gene.
